Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B110236-25mg | 25mg | In stock | $32.90 | |
B110236-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $107.90 | |
B110236-500mg | 500mg | In stock | $486.90 |
GABA A antagonist
Synonyms | (+)-Bicuculline|bicuculline|485-49-4|d-Bicuculline|Bicculine|Bicucullin|Bicuculline (+)|CHEBI:3092|CHEMBL417990|Y37615DVKC|NSC32192|NSC-32192|(6R)-6-[(5S)-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]furo[3,4-e][1,3]benzodioxol-8(6H)-one |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | GABA A antagonist. |
Storage Temp | Store at 2-8°C,Protected from light,Argon charged |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | ANTAGONIST, CHANNEL BLOCKER |
Mechanism of action | Antagonist of GABA A receptor α1 subunit;Antagonist of GABA A receptor α2 subunit;Antagonist of GABA A receptor α3 subunit;Antagonist of GABA A receptor α4 subunit;Antagonist of GABA A receptor α5 subunit;Antagonist of GABA A receptor α6 subunit;Channel b |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Toxic, refer to SDS for further information. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (6R)-6-[(5S)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6H-furo[3,4-g][1,3]benzodioxol-8-one |
---|---|
INCHI | InChI=1S/C20H17NO6/c1-21-5-4-10-6-14-15(25-8-24-14)7-12(10)17(21)18-11-2-3-13-19(26-9-23-13)16(11)20(22)27-18/h2-3,6-7,17-18H,4-5,8-9H2,1H3/t17-,18+/m0/s1 |
InChi Key | IYGYMKDQCDOMRE-ZWKOTPCHSA-N |
Canonical SMILES | CN1CCC2=CC3=C(C=C2C1C4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3 |
Isomeric SMILES | CN1CCC2=CC3=C(C=C2[C@H]1[C@H]4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3 |
WGK Germany | 3 |
RTECS | LV0909840 |
PubChem CID | 10237 |
UN Number | 1544 |
Molecular Weight | 367.35 |
Beilstein | 98786 |
Reaxy-Rn | 98786 |
PubChem CID | 10237 |
---|---|
ChEBI | CHEBI:3092 |
CAS Registry No. | 485-49-4 |
ChEMBL Ligand | CHEMBL417990 |
BindingDB Ligand | 50000693 |
Wikipedia | Bicuculline |
RCSB PDB Ligand | H0Z |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2311780 | Certificate of Analysis | Dec 19, 2022 | B110236 |
C2311781 | Certificate of Analysis | Dec 19, 2022 | B110236 |
C2311782 | Certificate of Analysis | Dec 19, 2022 | B110236 |
C2311783 | Certificate of Analysis | Dec 19, 2022 | B110236 |
C2314330 | Certificate of Analysis | Dec 19, 2022 | B110236 |
Solubility | Solubility in Chloroform almost transparency |
---|---|
Sensitivity | Air & light sensitive |
Specific Rotation[α] | +127.0 to +132.0 deg(C=1, CHCl3) |
Melt Point(°C) | 195-199°C |
Pictogram(s) | GHS06, GHS09 |
---|---|
Signal | Danger |
Hazard Statements | H311:Toxic in contact with skin H331:Toxic if inhaled H400:Very toxic to aquatic life H300:Fatal if swallowed H311+H331:Toxic in contact with skin or if inhaled. |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P273:Avoid release to the environment. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P391:Collect spillage. P330:Rinse mouth. P361+P364:Take off immediately all contaminated clothing and wash it before reuse. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P316:Get emergency medical help immediately. |
WGK Germany | 3 |
RTECS | LV0909840 |
Reaxy-Rn | 98786 |
Merck Index | 1203 |
1. Uwechue NM et al.. (2012) Activation of glutamate transport evokes rapid glutamine release from perisynaptic astrocytes.. J Physiol, 590 (Pt 10): (2317-31). [PMID:22411007] |
2. Ren L et al.. (2018) Anesthetics alleviate learning and memory impairment induced by electroconvulsive shock by regulation of NMDA receptor-mediated metaplasticity in depressive rats.. Neurobiol Learn Mem, 155 (65-77). [PMID:29953948] |
3. Anderson GR et al.. (2009) Changes in striatal signaling induce remodeling of RGS complexes containing Gbeta5 and R7BP subunits.. Mol Cell Biol, 29 (11): (3033-44). [PMID:19332565] |
4. Ye ZY et al.. (2012) Casein kinase 2-mediated synaptic GluN2A up-regulation increases N-methyl-D-aspartate receptor activity and excitability of hypothalamic neurons in hypertension.. J Biol Chem, 287 (21): (17438-46). [PMID:22474321] |
5. Martinello K et al.. (2015) Cholinergic afferent stimulation induces axonal function plasticity in adult hippocampal granule cells.. Neuron, 85 (2): (346-63). [PMID:25578363] |
6. Glasgow SD et al.. (2012) Cholinergic suppression of excitatory synaptic transmission in layers II/III of the parasubiculum.. Neuroscience, 201 (1-11). [PMID:22138154] |
7. Zhao YL et al.. (2012) Chronic opioid potentiates presynaptic but impairs postsynaptic N-methyl-D-aspartic acid receptor activity in spinal cords: implications for opioid hyperalgesia and tolerance.. J Biol Chem, 287 (30): (25073-85). [PMID:22679016] |
8. Dovgan AV et al.. (2010) Decoding glutamate receptor activation by the Ca2+ sensor protein hippocalcin in rat hippocampal neurons.. Eur J Neurosci, 32 (3): (347-58). [PMID:20704590] |
9. Mishra P & Narayanan R. (2022) Conjunctive changes in multiple ion channels mediate activity-dependent intrinsic plasticity in hippocampal granule cells.. iScience, 25 (3): (103922). [PMID:35252816] |
10. Pizzarelli R & Cherubini E. (2013) Developmental regulation of GABAergic signalling in the hippocampus of neuroligin 3 R451C knock-in mice: an animal model of Autism.. Front Cell Neurosci, 7 (85). [PMID:23761734] |
11. García-Junco-Clemente P et al.. (2010) Cysteine string protein-alpha prevents activity-dependent degeneration in GABAergic synapses.. J Neurosci, 30 (21): (7377-91). [PMID:20505105] |
12. Hetzel A et al.. (2012) Effect of amphetamine place conditioning on excitatory synaptic events in the basolateral amygdala ex vivo.. Neuroscience, 206 (7-16). [PMID:22280974] |
13. Bard L et al.. (2010) Dynamic and specific interaction between synaptic NR2-NMDA receptor and PDZ proteins.. Proc Natl Acad Sci U S A, 107 (45): (19561-6). [PMID:20974938] |
14. Suárez F et al.. (2010) Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.. Eur J Neurosci, 32 (3): (359-67). [PMID:20618827] |
15. Schröter M et al.. (2022) Functional imaging of brain organoids using high-density microelectrode arrays.. MRS Bull, 47 (6): (530-544). [PMID:36120104] |
16. Zonouzi M et al.. (2015) GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury.. Nat Neurosci, 18 (5): (674-82). [PMID:25821912] |
17. Li MH et al.. (2014) GABAergic transmission and enhanced modulation by opioids and endocannabinoids in adult rat rostral ventromedial medulla.. J Physiol, [PMID:25362151] |
18. Höft S et al.. (2014) Heterogeneity in expression of functional ionotropic glutamate and GABA receptors in astrocytes across brain regions: insights from the thalamus.. Philos Trans R Soc Lond B Biol Sci, 369 (1654): (20130602). [PMID:25225096] |
19. Le Roux N et al.. (2013) Input-specific learning rules at excitatory synapses onto hippocampal parvalbumin-expressing interneurons.. J Physiol, 591 (Pt 7): (1809-22). [PMID:23339172] |
20. Dingle YL et al.. (2021) Integrated functional neuronal network analysis of 3D silk-collagen scaffold-based mouse cortical culture.. STAR Protoc, 2 (100292). [PMID:33537680] |
21. Lanore F et al.. (2010) Impaired development of hippocampal mossy fibre synapses in mouse mutants for the presynaptic scaffold protein Bassoon.. J Physiol, 588 (Pt 12): (2133-45). [PMID:20421286] |
22. Huang Z et al.. (2009) Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis.. J Neurosci, 29 (35): (10979-88). [PMID:19726656] |
23. Vecchia D et al.. (2014) Mechanism underlying unaltered cortical inhibitory synaptic transmission in contrast with enhanced excitatory transmission in CaV2.1 knockin migraine mice.. Neurobiol Dis, 69 (225-34). [PMID:24907493] |
24. Chanda S & Xu-Friedman MA. (2010) Neuromodulation by GABA converts a relay into a coincidence detector.. J Neurophysiol, 104 (4): (2063-74). [PMID:20702743] |
25. Ye ZY et al.. (2012) NKCC1 upregulation disrupts chloride homeostasis in the hypothalamus and increases neuronal activity-sympathetic drive in hypertension.. J Neurosci, 32 (25): (8560-8). [PMID:22723696] |
26. Blazon M et al.. (2021) N-type calcium channels control GABAergic transmission in brain areas related to fear and anxiety.. OBM Neurobiol, 5 [PMID:33521586] |
27. Antonelli R et al.. (2014) Pin1-dependent signalling negatively affects GABAergic transmission by modulating neuroligin2/gephyrin interaction.. Nat Commun, 5 (5066). [PMID:25297980] |
28. Ye ZY et al.. (2011) Protein kinase CK2 increases glutamatergic input in the hypothalamus and sympathetic vasomotor tone in hypertension.. J Neurosci, 31 (22): (8271-9). [PMID:21632948] |
29. Malik AR et al.. (2019) SorCS2 Controls Functional Expression of Amino Acid Transporter EAAT3 and Protects Neurons from Oxidative Stress and Epilepsy-Induced Pathology.. Cell Rep, 26 (10): (2792-2804.e6). [PMID:30840898] |
30. Li DP et al.. (2012) Switch to glutamate receptor 2-lacking AMPA receptors increases neuronal excitability in hypothalamus and sympathetic drive in hypertension.. J Neurosci, 32 (372-80). [PMID:22219297] |
31. Renden R & von Gersdorff H. (2007) Synaptic vesicle endocytosis at a CNS nerve terminal: faster kinetics at physiological temperatures and increased endocytotic capacity during maturation.. J Neurophysiol, 98 (6): (3349-59). [PMID:17942618] |
32. Huang Z et al.. (2012) TRIP8b-independent trafficking and plasticity of adult cortical presynaptic HCN1 channels.. J Neurosci, 32 (42): (14835-48). [PMID:23077068] |
33. Bazelot M et al.. (2010) Unitary inhibitory field potentials in the CA3 region of rat hippocampus.. J Physiol, 588 (Pt 12): (2077-90). [PMID:20403979] |
34. Brady JD et al.. (2010) Vesicular GABA release delays the onset of the Purkinje cell terminal depolarization without affecting tissue swelling in cerebellar slices during simulated ischemia.. Neuroscience, 168 (108-17). [PMID:20226232] |